Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • Investor Portal
    • JOIN OUR TEAM
    • Contact

NEWS

Our Latest News

ARCHIMED buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED MedTech announces the definitive acquisition of Global Dental Technology Platform, ZimVie, in an approximately $730 million take-private deal.

ARCHIMED  buys Premium Global Dental Healthcare US Company ZimVie

ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients

 November

 18, 

2021

ARCHIMED buys Cardioline, Europe’s leader in cardiology-focused telemedicine

 November

 17, 

2021

ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market

 November

 3, 

2021

ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders

 October

 20, 

2021

ARCHIMED’s NAMSA returns more than a third of investment

 October

 7, 

2021

ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products

 October

 5, 

2021

< 1 … 6 7 8 9 10 … 17 >
368
  • ARCHIMED © 2026
  • Our Eco-Design Approach
  • Legal Notice
  • Contact Us
  • Videos
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top